0 results

Patient Corner

Anatomical Illustrations

More

Last reference updates

  • 16 Sep 2016 - Drug Updates

Posaconazole (Noxafil): tablets and oral suspension not interchangable

Different dosage forms of posaconazole should not be substituted for each other

Read more
  • 16 Sep 2016 - Drug Updates

Levonorgestrel-containing emergency contraceptives: interaction with hepatic enzyme inducers

Concomitant CYP3A4 enzyme inducers reduce the efficacy of levonorgestrel

Read more
  • 16 Sep 2016 - Drug Updates

Idelalisib (Zydelig▼): updated safety information on risk of infection

Treatment recommendations for idelalisib have been updated following conclusion of safety review

Read more
  • 10 Aug 2016 - Drug Updates

Lonsurf ▼(trifluridine/tipiracil) approved for colorectal cancer chemotherapy

Lonsurf has been approved in the UK for treatment of metastatic colorectal cancer

Read more
  • 9 Aug 2016 - Drug Updates

Riociguat (Adempas) contraindicated in pulmonary hypertension associated with idiopathic interstitial pneumonias

Patients with pulmonary hypertension associated with idiopathic interstitial pneumonias (PH-IIP) should not be treated with riociguat

Read more
  • 19 Jul 2016 - Drug Updates

N-acetylcysteine interference with Siemens assays: false-low test results

N-acetylcysteine may interfere with assays from Siemens ADVIA Chemistry and Dimension/Dimension Vista instruments

Read more
  • 19 Jul 2016 - Drug Updates

Suspected fatal drug interaction between citalopram and cocaine

Prescribers should consider possible illicit drug use when prescribing medicines with potential for interactions

Read more
  • 19 Jul 2016 - Drug Updates

Rare reports of calciphylaxis in patients taking warfarin

Warfarin linked to cases of calciphylaxis, a very rare but serious condition

Read more
  • 14 Jul 2016 - Drug Updates

Epclusa (sofosbuvir/velpatasvir) approved for treatment of chronic HCV infection

Epclusa is licensed in the UK for treatment of all 6 major genotypes of chronic HCV infection

Read more
  • 11 Jul 2016 - Drug Updates

Duavive (conjugated oestrogens/ bazedoxifene) approved for treatment of menopausal symptoms

Duavive (conjugated oestrogens/ bazedoxifene) is licensed for treatment of oestrogen deficiency symptoms in postmenopausal women

Read more